He, G <br/><br/>
Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.  [electronic resource] 

 -  European journal of clinical investigation  Sep 2005 
 - 583-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2972 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2362.2005.01547.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipose Tissue--metabolism<br/>Adult<br/>Body Mass Index<br/>Cytokines--analysis<br/>HIV-Associated Lipodystrophy Syndrome--blood<br/>Humans<br/>Insulin Resistance--physiology<br/>Interleukin-6--analysis<br/>Interleukin-8--analysis<br/>Male<br/>Middle Aged<br/>Plasminogen Activator Inhibitor 1--analysis<br/>RNA, Messenger--analysis<br/>Receptors, Tumor Necrosis Factor--analysis<br/>Serine Proteinase Inhibitors--analysis<br/>Tumor Necrosis Factor-alpha--analysis